BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reinhold JA, Rickels K. Pharmacological treatment for generalized anxiety disorder in adults: an update. Expert Opin Pharmacother 2015;16:1669-81. [PMID: 26159446 DOI: 10.1517/14656566.2015.1059424] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Sarris J, Byrne GJ, Cribb L, Oliver G, Murphy J, Macdonald P, Nazareth S, Karamacoska D, Galea S, Short A, Ee C, Birling Y, Menon R, Ng CH. L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. Journal of Psychiatric Research 2019;110:31-7. [DOI: 10.1016/j.jpsychires.2018.12.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 5.7] [Reference Citation Analysis]
2 Orsolini L, De Berardis D, Bellantuono C. The ‘hidden' and ‘forgotten' psychiatry: The Perinatal Psychiatry. RIVISTA SPERIMENTALE DI FRENIATRIA 2019. [DOI: 10.3280/rsf2019-001003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Balon R, Starcevic V. Role of Benzodiazepines in Anxiety Disorders. In: Kim Y, editor. Anxiety Disorders. Singapore: Springer; 2020. pp. 367-88. [DOI: 10.1007/978-981-32-9705-0_20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
4 Buoli M, Grassi S, Serati M, Altamura AC. Agomelatine for the treatment of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 2017;18:1373-9. [DOI: 10.1080/14656566.2017.1359257] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
5 Tomasi J, Lisoway AJ, Zai CC, Harripaul R, Müller DJ, Zai GC, Mccabe RE, Richter MA, Kennedy JL, Tiwari AK. Towards precision medicine in generalized anxiety disorder: Review of genetics and pharmaco(epi)genetics. Journal of Psychiatric Research 2019;119:33-47. [DOI: 10.1016/j.jpsychires.2019.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Buoli M, Caldiroli A, Serati M. Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder. Expert Opinion on Drug Metabolism & Toxicology 2016;13:351-9. [DOI: 10.1080/17425255.2017.1281247] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
7 Butler TR, Karkhanis AN, Jones SR, Weiner JL. Adolescent Social Isolation as a Model of Heightened Vulnerability to Comorbid Alcoholism and Anxiety Disorders. Alcohol Clin Exp Res 2016;40:1202-14. [PMID: 27154240 DOI: 10.1111/acer.13075] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 10.2] [Reference Citation Analysis]
8 Genario R, Giacomini AC, de Abreu MS, Marcon L, Demin KA, Kalueff AV. Sex differences in adult zebrafish anxiolytic-like responses to diazepam and melatonin. Neuroscience Letters 2020;714:134548. [DOI: 10.1016/j.neulet.2019.134548] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
9 Huang Z, Zhan S, Chen C, Li N, Ding Y, Hou Y, Wang L, Wang Y. The Effect of Insomnia on Cortical Excitability in Patients With Generalized Anxiety Disorder. Front Psychiatry 2018;9:755. [PMID: 30687140 DOI: 10.3389/fpsyt.2018.00755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Chen TR, Huang HC, Hsu JH, Ouyang WC, Lin KC. Pharmacological and psychological interventions for generalized anxiety disorder in adults: A network meta-analysis. J Psychiatr Res 2019;118:73-83. [PMID: 31494377 DOI: 10.1016/j.jpsychires.2019.08.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Li C, Lu C, Lin H, Huang Y, Juan C, Su T, Bai Y, Chen M, Lin W. Cortical inhibitory and excitatory function in drug-naive generalized anxiety disorder. Brain Stimulation 2017;10:604-8. [DOI: 10.1016/j.brs.2016.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
12 Michels H, Seinstra RI, Uitdehaag JC, Koopman M, van Faassen M, Martineau CN, Kema IP, Buijsman R, Nollen EA. Identification of an evolutionary conserved structural loop that is required for the enzymatic and biological function of tryptophan 2,3-dioxygenase. Sci Rep 2016;6:39199. [PMID: 27995966 DOI: 10.1038/srep39199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Martin EL, Strickland JC, Schlienz NJ, Munson J, Jackson H, Bonn-Miller MO, Vandrey R. Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial. Front Psychiatry 2021;12:729800. [PMID: 34566726 DOI: 10.3389/fpsyt.2021.729800] [Reference Citation Analysis]
14 Gomez AF, Barthel AL, Hofmann SG. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review. Expert Opin Pharmacother 2018;19:883-94. [PMID: 29806492 DOI: 10.1080/14656566.2018.1472767] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
15 Dong MX, Chen GH, Hu L. Dopaminergic System Alteration in Anxiety and Compulsive Disorders: A Systematic Review of Neuroimaging Studies. Front Neurosci 2020;14:608520. [PMID: 33343291 DOI: 10.3389/fnins.2020.608520] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Supasitthumrong T, Bolea-Alamanac BM, Asmer S, Woo VL, Abdool PS, Davies SJC. Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report. Br J Clin Pharmacol 2019;85:690-703. [PMID: 30575088 DOI: 10.1111/bcp.13844] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
17 Storch EA, Gregory S, Salloum A, Quast T. Psychopharmacology Utilization Among Children with Anxiety and Obsessive-Compulsive and Related Disorders Following Hurricane Katrina. Child Psychiatry Hum Dev 2018;49:632-42. [PMID: 29299728 DOI: 10.1007/s10578-017-0779-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Phipps S, Grundmann O. Pharmacology and Structure-Activity Relationship of Natural Products With Psychoactive Effects From Salvia divinorum , Mitragyna speciosa , and Ayahuasca. Elsevier; 2017. pp. 1-44. [DOI: 10.1016/b978-0-444-63930-1.00001-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Tayem YI, Jahrami HA, Ali MK, Hattab SW. Ambulatory Pharmacotherapy of Five Psychiatric Disorders in Bahrain: a Descriptive Study. Psychiatr Q 2020;91:289-98. [PMID: 31898212 DOI: 10.1007/s11126-019-09705-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Keefe JR, Mao JJ, Soeller I, Li QS, Amsterdam JD. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. Phytomedicine 2016;23:1699-705. [PMID: 27912871 DOI: 10.1016/j.phymed.2016.10.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
21 Paschoalin-maurin T, dos Anjos-garcia T, Falconi-sobrinho LL, de Freitas RL, Coimbra JPC, Laure CJ, Coimbra NC. The Rodent-versus-wild Snake Paradigm as a Model for Studying Anxiety- and Panic-like Behaviors: Face, Construct and Predictive Validities. Neuroscience 2018;369:336-49. [DOI: 10.1016/j.neuroscience.2017.11.031] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
22 Cohen SD, Cukor D, Kimmel PL. Anxiety in Patients Treated with Hemodialysis. Clin J Am Soc Nephrol. 2016;11:2250-2255. [PMID: 27660303 DOI: 10.2215/cjn.02590316] [Cited by in Crossref: 48] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
23 Mao JJ, Xie SX, Keefe JR, Soeller I, Li QS, Amsterdam JD. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine 2016;23:1735-42. [PMID: 27912875 DOI: 10.1016/j.phymed.2016.10.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
24 Rickels K, Moeller HJ. Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety. The World Journal of Biological Psychiatry 2019;20:514-8. [DOI: 10.1080/15622975.2018.1500031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Frank GK, Shott ME. The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects. CNS Drugs 2016;30:419-42. [PMID: 27106297 DOI: 10.1007/s40263-016-0335-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
26 Rincón-Cortés M, Gagnon KG, Dollish HK, Grace AA. Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine. Neuropsychopharmacology 2018;43:2418-25. [PMID: 29959439 DOI: 10.1038/s41386-018-0123-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
27 Goddard AW. Morbid Anxiety: Identification and Treatment. Focus (Am Psychiatr Publ) 2017;15:136-43. [PMID: 31975846 DOI: 10.1176/appi.focus.20160046] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Korn CW, Vunder J, Miró J, Fuentemilla L, Hurlemann R, Bach DR. Amygdala Lesions Reduce Anxiety-like Behavior in a Human Benzodiazepine-Sensitive Approach-Avoidance Conflict Test. Biol Psychiatry 2017;82:522-31. [PMID: 28364943 DOI: 10.1016/j.biopsych.2017.01.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
29 Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother 2018;19:1057-70. [PMID: 30056792 DOI: 10.1080/14656566.2018.1491966] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
30 Wang SM, Woo YS, Kim NY, Na HR, Lim HK, Bahk WM. Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis. Clin Psychopharmacol Neurosci 2020;18:423-33. [PMID: 32702221 DOI: 10.9758/cpn.2020.18.3.423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]